Clinical Trial

Mesotherapy for the Management of Myofascial Pain Syndrome

Completed
View on ClinicalTrials.gov →
Summary
Temporomandibular joint disorders represent a complex and heterogeneous group of musculoskeletal conditions affecting the temporomandibular joint,masticatory muscles, and associated structures, frequently manifesting as chronic orofacial pain. Temporomandibular joint (TMJ) disorders encompass a group of conditions affecting the jaw joint and associated musculature, leading to pain, impaired function, and a diminished quality of life. These disorders arise from various etiologies, including trauma,degenerative conditions such as osteoarthritis, and systemic inflammatory diseases, emphasizing their multifactorial nature. Although the mechanism of action of mesotherapy in TMJ disorders involves delivering anti-inflammatory and analgesic agents directly to the affected area,the literature reveals a significant research gap regarding its efficacy and longterm benefits.
Trial Details
NCT Number NCT07630909
Lead Sponsor Future University in Egypt
Conditions Myofascial Pain Syndrome (MPS)
Enrollment 22 participants
Start Date 2025-09-02
Primary Completion 2025-09-07 (estimated)
Study Completion 2025-09-09 (estimated)
Updated on ClinicalTrials.gov 2026-06-05